Cutler Group LP Ascendis Pharma A/S Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$123.45 - $159.4 $259,245 - $334,740	2,100 New	2,100 $6,000
Q1 2023 May 01, 2023	SELL	$104.9 - $126.78 $20,980 - $25,356	-200 Reduced 33.33%	400 $0
Q4 2022 Feb 07, 2023	SELL	$99.42 - $131.97 $298,260 - $395,910	-3,000 Reduced 83.33%	600 $0
Q3 2022 Oct 25, 2022	BUY	$84.03 - $110.23 $302,508 - $396,828	3,600 New	3,600 $50,000
Q1 2022 Apr 14, 2022	BUY	$102.18 - $135.75 $3.22 Million - $4.28 Million	31,500 New	31,500 $12,000
Q4 2021 Jan 18, 2022	SELL	$127.1 - $169.66 $38,130 - $50,898	-300 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$112.67 - $176.92 $33,801 - $53,075	300 New	300 $3,000
Q2 2021 Jul 19, 2021	SELL	$121.62 - $145.29 $364,860 - $435,870	-3,000 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$151.2 - $182.76 $272,160 - $328,968	1,800 Added 150.0%	3,000 $126,000
Q3 2020 Oct 27, 2020	SELL	$134.29 - $154.32 $241,722 - $277,776	-1,800 Reduced 60.0%	1,200 $3,000
Q2 2020 Jul 22, 2020	SELL	$110.87 - $156.01 $166,305 - $234,015	-1,500 Reduced 33.33%	3,000 $56,000
Q1 2020 May 07, 2020	SELL	$97.01 - $145.11 $979,801 - $1.47 Million	-10,100 Reduced 69.18%	4,500 $36,000
Q4 2019 Feb 06, 2020	BUY	$91.45 - $139.12 $1.06 Million - $1.61 Million	11,600 Added 386.67%	14,600 $355,000
Q3 2019 Oct 28, 2019	SELL	$95.8 - $118.9 $593,960 - $737,180	-6,200 Reduced 67.39%	3,000 $2,000
Q2 2019 Aug 09, 2019	SELL	$107.11 - $132.09 $2.21 Million - $2.72 Million	-20,600 Reduced 69.13%	9,200 $71,000
Q1 2019 May 10, 2019	BUY	$62.15 - $129.99 $758,230 - $1.59 Million	12,200 Added 69.32%	29,800 $444,000
Q4 2018 Feb 05, 2019	BUY	$55.16 - $69.67 $639,856 - $808,172	11,600 Added 193.33%	17,600 $75,000
Q3 2018 Nov 07, 2018	BUY	$63.77 - $76.28 $299,719 - $358,516	4,700 Added 361.54%	6,000 $40,000
Q2 2018 Aug 10, 2018	BUY	$58.55 - $73.92 $76,115 - $96,096	1,300 New	1,300 $3,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.31 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$691 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$672 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$594 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$564 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.51B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account